Effect of olmesartan on beta-cell function and diabetic angiopathy in type 2 diabeteic patients with hypertension

Trial Profile

Effect of olmesartan on beta-cell function and diabetic angiopathy in type 2 diabeteic patients with hypertension

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 May 2016

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Amlodipine
  • Indications Diabetic angiopathies; Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top